Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, is expanding its offerings in Latin America to help bring automated manufacturing to cell and gene therapy companies in Brazil, Colombia and Mexico.
 
Terumo BCT, with a focus on automation, makes products that collect, process and separate blood and cells, along with automated manufacturing platforms that support cell and gene therapy (CGT) developers.
 
“Across the cell and gene therapy sector, Terumo BCT is supporting the adoption of automation to help CGT companies scale their manufacturing,” said Eduardo Morato, Country Manager of Brazil, Terumo BCT. “Our ambition is that more patients will have access to these life-saving therapies because automated manufacturing helps streamline the process — leading to lower costs and the ability to manufacture more therapies.” 
 
Terumo BCT’s products support cell and gene therapy manufacturers throughout the development lifecycle. The technologies being introduced in Latin America are already used internationally. Availability varies by region and country. They include: 
 

• The Quantum Flex Cell Expansion System, a functionally closed, automated cell expansion system that enables process control for a variety of adherent cells, suspension cells, viral vectors and exosomes. 
• The FINIA Fill and Finish System, an automated system that formulates and aliquots fluids, including cell suspensions, to prepare for cryopreservation. It consists of a device, a handheld barcode scanner, a monitor with a touch screen and functionally closed single-use tubing sets.
• Terumo BCT’s portfolio of welders and sealers supports the needs of cell and gene therapy manufacturers throughout their processes.